Insider · CIK 0001975443
Dearborn Dan
cfoofficer
Files at HURA (Kintara Therapeutics, Inc.). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Nov 12, 2024 | HURA Kintara Therapeutics, Inc. | AGrant or award Options (Right to Buy)derivative | +489,848 | $0.00 | $0 | 489,848 | Nov 14, 2024 |
| Oct 18, 2024 | HURA Kintara Therapeutics, Inc. | AGrant or award Options (Right to Buy)derivative | +33,991 | $0.00 | $0 | 33,991 | Oct 22, 2024 |
| Oct 18, 2024 | HURA Kintara Therapeutics, Inc. | AGrant or award Options (Right to Buy)derivative | +68,438 | $0.00 | $0 | 68,438 | Oct 22, 2024 |
| Oct 18, 2024 | HURA Kintara Therapeutics, Inc. | AGrant or award Options (Right to Buy)derivative | +232,570 | $0.00 | $0 | 232,570 | Oct 22, 2024 |
| Oct 18, 2024 | HURA Kintara Therapeutics, Inc. | AGrant or award Options (Right to Buy)derivative | +15,744 | $0.00 | $0 | 15,744 | Oct 22, 2024 |
| Oct 18, 2024 | HURA Kintara Therapeutics, Inc. | AGrant or award Options (Right to Buy)derivative | +66,658 | $0.00 | $0 | 66,658 | Oct 22, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.